Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data

Published:2023-08-01 Issue:2 Volume:29 Page:58-63
ISSN:1307-9441
Container-title:Viral Hepatitis Journal
language:
Short-container-title:vhd

Author:

Damar Çakırca Tuba^ORCID,Yamazhan Tansu^ORCID,Yüksekkaya Esra^ORCID,Akgül Fethiye^ORCID,Kurtaran Behice^ORCID,Karaşahin Ömer^ORCID,Karabay Oğuz^ORCID,Ünlü Gülten^ORCID,Can İlkay Nur^ORCID,Pullukçu Hüsnü^ORCID,Taşova Yeşim^ORCID,Kömür Süheyla^ORCID,Yıldız Yeşim^ORCID,Mermutluoğlu Çiğdem^ORCID,Demir Yakup^ORCID,Çelen Mustafa Kemal^ORCID

Publisher

Galenos Yayinevi

Subject

General Medicine

Reference14 articles.

1. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

2. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol. 2018;69:461-511.

3. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection;AASLD-IDSA HCV Guidance Panel;Clin Infect Dis,2018

4. Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection;Bourlière M;N Engl J Med,2017

5. Vosevi [prescribing information]. Foster City, CA: Gilead Sciences, Inc; 2017.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP